IP Verse

Arven Ilac Sanayi Ve Ticaret A.s. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Arven Ilac Sanayi Ve Ticaret A.s.

Patent Number:
EP2400950
Title:
Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol
Applicant:
GLAXO GROUP LIMITED
Opposition Date:
Feb 14, 2020

Latest patents of Arven Ilac Sanayi Ve Ticaret A.s. opposed by its competitors

Patent:
EP2682099
Grant Date:
Sep 2, 2020
Title:
Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists
Oppositions:
3
Patent:
EP2957552
Grant Date:
Jan 22, 2020
Title:
Vilanterol Formulations
Oppositions:
3
Patent:
EP2957551
Grant Date:
Jan 15, 2020
Title:
Dry Powder Formulations Comprising Vilanterol
Oppositions:
4
Patent:
EP3166641
Grant Date:
Sep 12, 2018
Title:
A Process For The Preparation Of Formulations For Inhalation
Oppositions:
1

Competitors of Arven Ilac Sanayi Ve Ticaret A.s.

BECK GREENER LLP

GILL JENNINGS & EVERY LLP

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Want to track Arven Ilac Sanayi Ve Ticaret A.s.?

Feel free to send us a message here and we will get back to you